JANSSEN-ORTHO
Career Opportunities family
family
CUSTOMER RESPONSE CENTRE
Tylenol
Important Changes to the Dose Conversion Guidelines for DURAGESIC* fentanyl transdermal system
New Indication VELCADE* (bortezomib) Front Line Multiple Myeloma
Important Information on the EVRA* Transdermal System
© Janssen-Ortho Inc. 2000 - 2009    Date Last Updated 03/18/09
This site is published by Janssen-Ortho Inc. which is solely responsible
for its contents. It is intended only for visitors from Canada.
Search | Site Map | Feed Back | Privacy | Francais | Legal Notice